Tag: #Global Trends

On February 25, 2026, the U.S. Food and Drug Administration (FDA) issued full approval for Pfizer’s Braftovi (encorafenib) in combination... Read more

Novartis has unveiled plans to construct a new radioligand therapy (RLT) manufacturing facility in Denton, Texas. This project marks a... Read more

Gilead Sciences has released detailed results from two pivotal clinical trials, Artistry-1 and Artistry-2, evaluating a novel investigational combination tablet... Read more

Bioprocessing leaders NorthX Biologics and Demeetra have launched a strategic collaboration designed to help biotech companies rapidly reach Investigational New... Read more

Pharmaceutical giant AbbVie has unveiled plans to invest $380 million in the construction of two new active pharmaceutical ingredient (API)... Read more

Merck & Co. has announced a major reorganization of its "Human Health" organization to better prepare for the upcoming loss... Read more

A cohort of premier venture capital firms has invested $130 million into Slate Medicines, a newly established startup based in... Read more

Novo Nordisk has announced a strategic move to broaden patient access in the U.S. market. Starting January 1, 2027, the... Read more

Just one month after the approval of Zycubo for Menkes disease, Fortress Biotech has announced an agreement to sell its... Read more